BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 7073083)

  • 1. Chemotaxis of horse polymorphonuclear leukocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Zinkl JG; Brown PD
    Am J Vet Res; 1982 Apr; 43(4):613-6. PubMed ID: 7073083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokinetic activity of N-formyl-methionyl-leucyl-phenylalanine on human neutrophils, and its modulation by phenylbutazone.
    Perianin A; Labro MT; Hakim J
    Biochem Pharmacol; 1982 Oct; 31(19):3071-6. PubMed ID: 6756410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wheat germ agglutinin specifically inhibits formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
    Perez HD; Ong R; Khanna K; Banda D; Goldstein IM
    J Immunol; 1982 Dec; 129(6):2718-24. PubMed ID: 6897258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG; Keeling PJ; Henson PM
    J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oriented migration of rat polymorphonucleocytes induced by 4-hydroxynonenal and formylmethionyl-leucyl-phenylalanine].
    Curzio M; Torriello MV; Dianzani MU
    Boll Soc Ital Biol Sper; 1982 Dec; 58(24):1672-8. PubMed ID: 6897768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan and the ionophore A23187.
    Palmer RM; Salmon JA
    Immunology; 1983 Sep; 50(1):65-73. PubMed ID: 6309653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotaxis of radiolabeled equine neutrophils.
    Camp CJ; Leid RW
    Am J Vet Res; 1982 Mar; 43(3):397-401. PubMed ID: 7073055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonists of the formylated peptide chemoattractants: structure-activity comparisons with formyl-methionyl-leucyl-phenylalanine-OH.
    Freer RJ; Day AR; Muthukumaraswamy N; Showell HJ; Becker EL
    Kroc Found Ser; 1981; 14():161-8. PubMed ID: 6947071
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the membrane fluidity of human neutrophilic granulocytes under the effect of a chemoattractant (FMLP) and of echo virus, type 9, A. Barty strain].
    Bültmann BD; Melzner I; Haferkamp O; Gruler H
    Acta Histochem Suppl; 1983; 28():209-11. PubMed ID: 6412297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of granulocyte adhesiveness by the chemotactic peptide N-formyl-L-methionyl-L-phenylalanine.
    Patrone F; Dallegri F; Sacchetti C
    Res Exp Med (Berl); 1980; 177(1):19-22. PubMed ID: 7403684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in polymorphonuclear leukocyte aggregating responses among several species in response to chemotactic stimulation.
    Oseas RS; Boxer LA; Butterick C; Baehner RL
    J Lab Clin Med; 1980 Aug; 96(2):213-21. PubMed ID: 7400660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
    Perez HD; Elfman F; Lobo E; Sklar L; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1803-12. PubMed ID: 3753993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF; Yuen C; Perez HD; Goldstein IM
    J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
    Fletcher MP
    J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD; Elfman F; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I; Kawasaki M; Matsuda A; Kataoka M; Kokurba Y
    Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a chemotactic factor, N-formylmethionyl peptide, on adherence, superoxide anion generation, phagocytosis, and microtubule assembly of human polymorphonuclear leukocytes.
    Boxer LA; Yoder M; Bonsib S; Schmidt M; Ho P; Jersild R; Baehner RL
    J Lab Clin Med; 1979 Mar; 93(3):506-14. PubMed ID: 219119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine.
    Anderson DC; Hughes BJ; Smith CW
    J Clin Invest; 1981 Oct; 68(4):863-74. PubMed ID: 7287906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulus- and cumulative dose-dependent inhibition of O2- production by polymorphonuclear leukocytes of patients receiving corticosteroids.
    Fukushima K; Ando M; Ito K; Suga M; Araki S
    J Clin Lab Immunol; 1990 Nov; 33(3):117-23. PubMed ID: 1967000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.